Page 265 - Read Online

Cao Cancer Evo-Dev

J, Han X, Zhang H, Cao G. HLA-DP polymorphisms affect the 2012;481:306-13.
outcomes of chronic hepatitis B virus infections, possibly through 81. Stratton MR. Exploring the genomes of cancer cells: progress and
interacting with viral mutations. J Virol 2013;87:12176-86. promise. Science 2011;331:1553-8.
62. Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G. Impacts 82. Xu X, Chang W, Yuan J, Han X, Tan X, Ding Y, Luo Y, Cai H, Liu
of human leukocyte antigen DQ genetic polymorphisms and their Y, Gao X, Liu Q, Yu Y, Du Y, Wang H, Ma L, Wang J, Chen K, Ding
interactions with hepatitis B virus mutations on the risks of viral Y, Fu C, Cao G. Periostin expression in intra-tumoral stromal cells
persistence, liver cirrhosis, and hepatocellular carcinoma. Infect Genet is prognostic and predictive for colorectal carcinoma via creating a
Evol 2014;28:201-9. cancer-supportive niche. Oncotarget 2016;7:798-813.
63. Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu R, Shen Q, Lu W, Du 83. Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, Kawasaki
Y, Zhao J, Han X, Zhang H, Cao G. Interaction of signal transducer A, Ong CW, Wong KF, Lee S, Ravikumar S, Srivastava S, Tian X,
and activator of transcription 3 polymorphisms with hepatitis B virus Poon RT, Fan ST, Luk JM, Dan YY, Salto-Tellez M, Chai L, Tenen
mutations in hepatocellular carcinoma. Hepatology 2013;57:2369-77. DG. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
64. Zhang Q, Ji XW, Hou XM, Lu FM, Du Y, Yin JH, Sun XY, Deng Y, N Engl J Med 2013;368:2266-76.
Zhao J, Han X, Yang GS, Zhang HW, Chen XM, Shen HB, Wang 84. Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y, Nomura
HY, Cao GW. Effect of functional nuclear factor-kappaB genetic Y, Yoshida M, Hayashi T, Oishi N, Ikeda H, Honda M, Kaneko S. The
polymorphisms on hepatitis B virus persistence and their interactions transcription factor SALL4 regulates stemness of EpCAM-positive
with viral mutations on the risk of hepatocellular carcinoma. Ann hepatocellular carcinoma. J Hepatol 2014;60:127-34.
Oncol 2014;25:2413-9. 85. Moeini A, Sia D, Zhang Z, Camprecios G, Stueck A, Dong H, Montal
65. He Y, Zhang H, Yin J, Xie J, Tan X, Liu S, Zhang Q, Li C, Zhao R, Torrens L, Martinez-Quetglas I, Fiel MI, Hao K, Villanueva
J, Wang H, Cao G. IkappaBalpha gene promoter polymorphisms A, Thung SN, Schwartz ME, Llovet JM. Mixed hepatocellular
are associated with hepatocarcinogenesis in patients infected with cholangiocarcinomatumors: cholangiolocellular carcinoma is a
hepatitis B virus genotype C. Carcinogenesis 2009;30:1916-22. distinct molecular entity. J Hepatol 2017;66:952-61.
66. Wang S, Zhang J, Jiao W, Li J, Xun X, Sun Y, Guo X, Huan P, Dong 86. Fan H, Cui Z, Zhang H, Mani SK, Diab A, Lefrancois L, Fares N,
B, Zhang L, Hu X, Sun X, Wang J, Zhao C, Wang Y, Wang D, Huang Merle P, Andrisani O. DNA demethylation induces SALL4 gene re-
X, Wang R, Lv J, Li Y, Zhang Z, Liu B, Lu W, Hui Y, Liang J, Zhou expression in subgroups of hepatocellular carcinoma associated with
Z, Hou R, Li X, Liu Y, Li H, Ning X, Lin Y, Zhao L, Xing Q, Dou Hepatitis B or C virus infection. Oncogene 2017;36:2435-45.
J, Li Y, Mao J, Guo H, Dou H, Li T, Mu C, Jiang W, Fu Q, Fu X, 87. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi
Miao Y, Liu J, Yu Q, Li R, Liao H, Li X, Kong Y, Jiang Z, Chourrout DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F,
D, Li R, Bao Z. Scallop genome provides insights into evolution of Roskams T, Thorgeirsson SS. A novel prognostic subtype of human
bilaterian karyotype and development. Nat Ecol Evol 2017;1:120. hepatocellular carcinoma derived from hepatic progenitor cells. Nat
67. Deschamps J, Duboule D. Embryonic timing, axial stem cells, Med 2006;12:410-6.
chromatin dynamics, and the Hox clock. Genes Dev 2017;31:1406-16. 88. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY,
68. Hinaux H, Devos L, Blin M, Elipot Y, Bibliowicz J, Alié A, Rétaux S. Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K,
Sensory evolution in blind cavefish is driven by early embryonic events Califano A, Iavarone A. The transcriptional network for mesenchymal
during gastrulation and neurulation. Development 2016;143:4521-32. transformation of brain tumours. Nature 2010;463:318-25.
69. Lettice LA, Devenney P, De Angelis C, Hill RE. The conserved Sonic 89. Yu J, Yu J, Rhodes DR, Tomlins SA, Cao X, Chen G, Mehra R, Wang
Hedgehog limb enhancer consists of discrete functional elements that X, Ghosh D, Shah RB, Varambally S, Pienta KJ, Chinnaiyan AM. A
regulate precise spatial expression. Cell Rep 2017;20:1396-408. polycomb repression signature in metastatic prostate cancer predicts
70. Rodrigues AR, Yakushiji-Kaminatsui N, Atsuta Y, Andrey G, cancer outcome. Cancer Res 2007;67:10657-63.
Schorderet P, Duboule D, Tabin CJ. Integration of Shh and 90. DiMeo TA, Anderson K, Phadke P, Fan C, Perou CM, Naber S,
Fgfsignaling in controlling Hox gene expression in cultured limb Kuperwasser C. A novel lung metastasis signature links Wnt signaling
cells. Proc Natl Acad Sci U S A 2017;114:3139-44. with cancer cell self-renewal and epithelial-mesenchymal transition in
71. Tarazona OA, Slota LA, Lopez DH, Zhang G, Cohn MJ. The genetic basal-like breast cancer. Cancer Res 2009;69:5364-73.
program for cartilage development has deep homology within 91. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A,
Bilateria. Nature 2016;533:86-9. Weinberg RA. An embryonic stem cell-like gene expression signature
72. Zhong C, Zhou YK, Yang SS, Zhao JF, Zhu XL, Chen HH, Chen in poorly differentiated aggressive human tumors. Nat Genet
PC, Huang LQ, Huang X. Developmental expression of the N-myc 2008;40:499-507.
downstream regulated gene (Ndrg) family during Xenopustropicalis 92. Chen H, He X. The convergent cancer evolution toward a single
embryogenesis. Int J Dev Biol 2015;59:511-7. cellular destination. Mol Biol Evol 2016;33:4-12.
73. Roush W, Pennisi E. Growing pains: evo-devo researchers straddle 93. Qin Y, Tang B, Hu CJ, Xiao YF, Xie R, Yong X, Wu YY, Dong H,
cultures. Science 1997;277:38-9. Yang SM. An hTERT/ZEB1 complex directly regulates E-cadherin
74. Akam M. The Yin and Yang of Evo/Devo. Cell 1998;92:153-5. to promote epithelial-to-mesenchymal transition (EMT) in colorectal
75. Raff RA. Evo-devo: the evolution of a new discipline. Nat Rev Genet cancer. Oncotarget 2016;7:351-61.
2000;1:74-9. 94. Chen J, Chan AW, To KF, Chen W, Zhang Z, Ren J, Song C,
76. De Robertis EM. Evo-devo: variations on ancestral themes. Cell Cheung YS, Lai PB, Cheng SH, Ng MH, Huang A, Ko BC. SIRT2
2008;132:185-95. overexpression in hepatocellular carcinoma mediates epithelial to
77. Carroll SB. Evo-devo and an expanding evolutionary synthesis: a mesenchymal transition by protein kinase B/glycogen synthase
genetic theory of morphological evolution. Cell 2008;134:25-36. kinase-3β/β-catenin signaling. Hepatology 2013;57:2287-98.
78. Nowell PC. The clonal evolution of tumor cell populations. Science 95. Chen T, You Y, Jiang H, Wang ZZ. Epithelial-mesenchymal
1976;194:23-8. transition (EMT): a biological process in the development, stem cell
79. Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary differentiation, and tumorigenesis. J Cell Physiol 2017;232:3261-72.
and ecological process. Nat Rev Cancer 2006;6:924-35. 96. Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton
80. Greaves M, Maley CC. Clonal evolution in cancer. Nature MR. Signatures of mutational processes in human cancer. Nature

Hepatoma Research ¦ Volume 3 ¦ October 27, 2017 257